Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
BBIO
BBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BBIO News
BridgeBio Presents Interim Data for BBP-418 at MDA Conference
5d ago
NASDAQ.COM
BridgeBio Pharma Q4 2025 Earnings Call Insights
Feb 25 2026
seekingalpha
BridgeBio (BBIO) Q4 2025 Earnings Call Transcript
Feb 25 2026
NASDAQ.COM
BridgeBio Pharma Q4 Earnings Beat Expectations with Strong Revenue Growth
Feb 24 2026
seekingalpha
BridgeBio Pharma to Announce Q4 Earnings on February 24
Feb 23 2026
seekingalpha
BridgeBio Pharma to Participate in Multiple Healthcare Investor Conferences
Feb 23 2026
Newsfilter
Worst Performing Large-Cap Stocks Last Week
Feb 22 2026
Benzinga
Cormorant Increases MoonLake Stake Above 6%
Feb 18 2026
stocktwits
BridgeBio Pharma Approves Employee Equity Grants
Feb 17 2026
Newsfilter
BridgeBio to Release Q4 and Full Year 2025 Financial Results
Feb 17 2026
Newsfilter
BridgeBio Pharma Stock Soars on Positive Clinical Trial Results
Feb 12 2026
Benzinga
BRIDGEBIO STOCK RISES 10.44% FOLLOWING FAVORABLE LATE-STAGE TRIAL OUTCOMES FOR ORAL GENETIC DISORDER TREATMENT
Feb 12 2026
moomoo
BridgeBio Pharma Shares Surge 13% After Successful Phase 3 Trial of Infigratinib
Feb 12 2026
seekingalpha
BridgeBio Reports Positive Phase-3 Data for Infigratinib
Feb 12 2026
stocktwits
BridgeBio Reports Positive Results from PROPEL 3 Study
Feb 12 2026
Newsfilter
U.S. Markets End Thursday in Decline; Estee Lauder Experienced the Largest Drop
Feb 05 2026
Barron's
Show More News
